Table 1 Baseline characteristics of patients with hypertrophic cardiomyopathy.
Variables | ED visit (-) N = 11,333 | ED visits ( +) N = 3209 | P value |
|---|---|---|---|
Age, years | 62.3 ± 13.2 | 66.8 ± 13.8 | < 0.001 |
Men, n (%) | 7511 (66.3) | 1843 (57.4) | < 0.001 |
Low-income, a n (%) | 2009 (17.7) | 699 (21.8) | 0.002 |
Comorbidities, n (%) | |||
Hypertension | 6771 (59.8) | 2146 (66.9) | < 0.001 |
Diabetes mellitus | 1952 (17.2) | 737 (23.0) | < 0.001 |
Dyslipidemia | 5680 (50.1) | 1617 (50.4) | 0.131 |
Heart failure | 3782 (33.4) | 1530 (47.7) | < 0.001 |
Stroke/TIA/thromboembolism | 1629 (14.4) | 855 (26.6) | < 0.001 |
Myocardial infarction | 570 (5.03) | 308 (9.6) | < 0.001 |
Atrial fibrillation/flutter | 1817 (16.0) | 842 (26.2) | < 0.001 |
COPD | 1129 (10.0) | 523 (16.3) | < 0.001 |
Chronic kidney disease | 887 (7.8) | 460 (14.3) | < 0.001 |
ICD implanted, n (%) | 210 (1.9) | 75 (2.3) | 0.047 |
Disease duration of HCM, months | 70.0 ± 64.4 | 61.3 ± 65.6 | < 0.001 |